Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
New Delhi [India], March 28 (ANI): Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath Kovind on Monday.
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.
New Delhi [India], February 2 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Wednesday welcomed the Union Budget 2022 and said that during COVID-19 pandemic budget outlay in the healthcare sector and vaccine self-reliance has helped the biotech industry.
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.
New Delhi [India], January 25 (ANI): Bharat Biotech Chairman Krishna Ella and co-founder Suchitra Ella will be conferred with Padma Bhushan on the 73rd Republic Day.
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
New Delhi [India], January 18 (ANI): Following reports of unapproved COVID vaccines being given to 15-18 year age group, Bharat Biotech on Tuesday requested healthcare workers to ensure that only COVAXIN is administered to individuals of the group.